IRS1 and type 2 diabetes mellitus: The free fatty acids interfere with the insulin signaling pathway by increasing the levels of reactive oxygen species, diacylglycerol and protein kinase C. There are further alterations in the phosphorylation of insulin receptor substrate‐1 (IRS‐1) which then affect Beta‐cell function with further insulin resistance, metabolic dysregulation and finally T2DM.